Work

ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s

Year: 2017

Type: article

Source: Mucosal Immunology

DOI: 10.1038/mi.2017.42

Authors: C L Hrusch, S T Manns, D Bryazka, J Casaos, C A Bonham, M R Jaffery, K M Blaine, K A M Mills, P A Verhoef, A O Adegunsoye, J W Williams, M Y Tjota, T V Moore, M E Strek, I Noth, A I Sperling

Institution: University of Chicago

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: University of Chicago, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: G1257341111, Summer Program to Increase Diversity in Biomedical Research & Physician Workforce - Renewal 01, Human Lung T cell subsets in Disease, IRF4+ respiratory dendritic cells in type 2 inflammatory responses, G406168540, Airway inflammation and HLA-G in asthma, Type 2 Immune Responses Protect Against the Morbidity and Mortality of Sepsis, Translational Research at The University of Chicago (UL1), G6482070679, Training of Junior Faculty for Careers in Omics of Lung Diseases, G8940433359, Cancer Center Support Grant, Research training in respiratory biology

OpenAlex ID: W2612175718

FWCI: 1.977

Cites: 36

Cited by: 34

Related to: 10